October 28, 8:00AM CT—Expert Theater at the ACEP Unconventional Annual Meeting

When Assessing Infection and Sepsis in the ED, Think Patient not Pathogen: Use Immune Response for Diagnosis and COVID Severity Risk Prediction

Host-Response Diagnostics

Delivering precision medicine on demand

SEE OUR PIPELINE

TEDx Palo Alto:
The power of reading the immune system to better diagnose disease

Dr. Tim Sweeney, Inflammatix Co-Founder and CEO

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people

host-response-diagram

In the News: Game Changing Impact

Recent notable news stories

October 8, 2020

Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform

Link to story

September 30, 2020

Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk

Link to story

September 8, 2020

Three Predictions For Healthcare Platforms

Link to story

August 24, 2020

Inflammatix sponsors Sepsis Heroes and Sepsis Alliance Summit

Sepsis Heroes | Sepsis Alliance Summit

Also covered by

SEE ALL NEWS

Stay in touch with Twitter updates: Find out the latest news.

Connect with Twitter